Abstract:A combination of chemotherapy and phototherapy has emerged as a promising strategy for cancer treatment. To achieve effective combinational therapy of cancer with reduced toxicity, it is highly desirable to improve the targeting of chemotherapeutic and near-infrared photosensitizers to enhance their accumulation in tumor. Here we report a novel tumor targeting cell membrane capsule (CMC), originate from living cells, to load doxorubicin hydrochloride (DOX) and indocyanine green (ICG), for combinational photo-chemotherapy against cancer. As a result, folic acid modified CMC (CMC-FA, with a diameter about 200 nm and a FA density of 0.4 molecule/nm(2)) showed 3-4 fold higher cell uptake by cancer cells in vitro and 2.3 times higher accumulation in mouse cancer xenografts in vivo than pristine CMC. DOX and ICG with therapeutically significant concentrations can be sequentially encapsulated into CMC-FA by temporary permeating the plasma membranes with high efficiency. The systematic administration of cancer targeting CMC-FA loaded with DOX and ICG could significantly inhibit tumor growth in mouse xenografts in the presence of a near-infrared light at 808 nm, without noticeable toxicity. These findings suggest that cancer targeting CMC may have considerable benefits in drug delivery and combinational cancer therapy. Statement of Significance A combination of chemotherapy and photothermal/photodynamic therapy has emerged as a promising strategy for cancer therapy. In current study, a novel cancer targeting cell membrane capsule (CMCFA), originate from living cells and surface modified with folic acid, was developed to load doxorubicin hydrochloride (DOX) and indocyanine green (ICG), for combinational photo-chemotherapy against cancer. The systematic administration of drug loaded CMC-FA can significantly inhibit tumor growth in mouse xenografts in the presence of a near-infrared light at 808 nm, without noticeable toxicity. This study provides a simple and robust strategy to develop biocompatible therapeutic cell membrane capsules, holds strong translational potential in precise cancer treatment. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Folate-Mediated And Doxorubicin-Conjugated Poly(Epsilon-Caprolactone)-G-Chondroitin Sulfate Copolymers For Enhanced Intracellular Drug Delivery

Folic Acid Modified Cell Membrane Capsules Encapsulating Doxorubicin and Indocyanine Green for Highly Effective Combinational Therapy in Vivo.

Folate-decorated Maleilated Pullulan–doxorubicin Conjugate for Active Tumor-Targeted Drug Delivery

Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells

Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells.

Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin

Folate-Conjugated Amphiphilic Block Copolymer Micelle For Targeted And Redox-Responsive Delivery Of Doxorubicin

Folate-decorated Chitosan/doxorubicin Poly(butyl)cyanoacrylate Nanoparticles for Tumor-Targeted Drug Delivery

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Folate-Conjugated Polyphosphoester with Reversible Cross-Linkage and Reduction Sensitivity for Drug Delivery

Synthesis, Characterization, Cellular Uptake, and in Vitro Anticancer Activity of Fullerenol-Doxorubicin Conjugates

Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.

Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy.

Folate-conjugated pH-responsive nanocarrier designed for active tumor targeting and controlled release of doxorubicin

Folate‐decorated Polysaccharide‐doxorubicin Polymer: Synthesis, Characterization, and Activity in HeLa Cells

Folate-conjugated amphiphilic block copolymers for targeted and efficient delivery of doxorubicin.

Synthesis and Evaluation of a Folate-linked Anti-cancer Prodrug

Prodrug of Folate-mediated Pullulan-doxorubicin Polymer:Preparation,Characterization and Biological Evaluation

Erratum To: Folate-conjugated Chitosan–polylactide Nanoparticles for Enhanced Intracellular Uptake of Anticancer Drug

Folate-functionalized Assembly of Low Density Lipoprotein/sodium Carboxymethyl Cellulose Nanoparticles for Targeted Delivery.

Correction to “targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”